Ultragenyx Pharmaceutical reported $-225066000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Agios Pharmaceuticals AGIO:US USD -86647000 8.29M
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Aptinyx Inc APTX:US USD -14657000 2.45M
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -84781000 22.62M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Insmed INSM:US USD -127697000 39.38M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Kyowa Hakko Kirin 4151:JP JPY 17.56B 4.15B
Macrogenics MGNX:US USD -24955000 16.85M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Moderna Inc MRNA:US USD 1.17B 1.28B
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Puma Biotechnology PBYI:US USD 2.39M 9.61M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Sarepta Therapeutics SRPT:US USD -256796000 45.66M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M
Vital Therapies VTL:US USD -20116000 494K
Xoma XOMA:US USD -4372000 395K